Rigel Pharmaceuticals, Inc. (RIGL)
47.38
+0.17
(+0.36%)
USD |
NASDAQ |
Dec 04, 16:00
47.41
+0.03
(+0.06%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap: 860.01M for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 907.99B |
| Amicus Therapeutics, Inc. | 3.070B |
| Vertex Pharmaceuticals, Inc. | 116.04B |
| PTC Therapeutics, Inc. | 6.250B |
| NovaBay Pharmaceuticals, Inc. | 137.35M |
Market Cap Related Metrics
| PE Ratio | 7.684 |
| PS Ratio | 3.085 |
| PEG Ratio | 0.0028 |
| Price to Book Value | 7.312 |
| Price to Free Cash Flow | 12.77 |
| Price | 47.38 |
| Earnings Yield | 13.01% |
| PEGY Ratio | 0.0028 |
| Operating PE Ratio | 7.316 |
| Normalized PE Ratio | 7.684 |